HOSPITAL UNIVERSITARIO RUBER

2019

1. Clinical Characterization of Immunotherapy-Related Pruritus among Patients Seen in 2 Oncodermatology Clinics

   JAMA Dermatology

2. Corrigendum: Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis (Annals of Oncology (2012) 23 (1130-1137) DOI: 10.1093/annonc/mdr432)

   Annals of Oncology

3. Corrigendum: Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab (Annals of Oncology (2017) 28 (761-768) DOI: 10.1093/annonc/mdw695)

   Annals of Oncology

4. Corrigendum: Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer (Annals of Oncology (2014) 25 (592–598) DOI: 10.1093/annonc/mdt543)

   Annals of Oncology

5. Corrigendum: Phase i safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors (Annals of Oncology (2012) 23 (463–471) (DOI: 10.1093/annonc/mdr137)

   Annals of Oncology

6. Corrigendum: Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors (Annals of Oncology (2012) 23 (897-902) (DOI: 10.1093/annonc/mdr348)

   Annals of Oncology

7. Cryosurgical management of basal cell carcinoma: in vivo follow-up using reflectance confocal microscopy

   International Journal of Dermatology

8. Nuevos abordajes en la epiduroscopia para el síndrome de cirugía lumbar fallida. Nuevas oportunidades

   Revista de la Sociedad Espanola del Dolor

9. Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion

   Journal of the American College of Cardiology